Cargando…
Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450204/ https://www.ncbi.nlm.nih.gov/pubmed/36128203 http://dx.doi.org/10.31138/mjr.33.2.237 |
| _version_ | 1784784474711523328 |
|---|---|
| author | Alkan, Arif Ugurlu, Serdal |
| author_facet | Alkan, Arif Ugurlu, Serdal |
| author_sort | Alkan, Arif |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9450204 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Mediterranean Journal of Rheumatology (MJR) |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94502042022-09-19 Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders Alkan, Arif Ugurlu, Serdal Mediterr J Rheumatol Original The Mediterranean Journal of Rheumatology (MJR) 2022-06-30 /pmc/articles/PMC9450204/ /pubmed/36128203 http://dx.doi.org/10.31138/mjr.33.2.237 Text en © 2022 The Mediterranean Journal of Rheumatology (MJR) https://creativecommons.org/licenses/by/4.0/This work is licensed under and Creative Commons Attribution-NonCommercial 4.0 International License. |
| spellingShingle | Original Alkan, Arif Ugurlu, Serdal Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders |
| title | Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders |
| title_full | Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders |
| title_fullStr | Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders |
| title_full_unstemmed | Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders |
| title_short | Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders |
| title_sort | canakinumab might be protective against severe covid-19 for patients with autoinflammatory disorders |
| topic | Original |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450204/ https://www.ncbi.nlm.nih.gov/pubmed/36128203 http://dx.doi.org/10.31138/mjr.33.2.237 |
| work_keys_str_mv | AT alkanarif canakinumabmightbeprotectiveagainstseverecovid19forpatientswithautoinflammatorydisorders AT ugurluserdal canakinumabmightbeprotectiveagainstseverecovid19forpatientswithautoinflammatorydisorders |